Stereotactic ventral pallidotomy for Parkinson's disease

Area of Science:

• Neurosurgery
• Neurology
• Movement Disorders

Background:

• Parkinson's disease (PD) is a progressive neurodegenerative disorder.
• Medically intractable PD presents with debilitating motor symptoms like bradykinesia, rigidity, and fluctuations.
• Current medical therapies often fail to provide adequate long-term symptom control.

Purpose of the Study:

• To evaluate the efficacy and safety of stereotactic ventral pallidotomy for medically intractable Parkinson's disease.
• To assess the impact of pallidotomy on motor function, dyskinesia, and overall quality of life.

Main Methods:

• Eighteen patients with intractable PD underwent stereotactic ventral pallidotomy under local anesthesia.
• Targeting utilized MRI, intraoperative recordings, and electrical stimulation.
• A control group of seven non-surgically treated patients was followed.
• Motor function was assessed at baseline and quarterly for one year.

Main Results:

• Ventral pallidotomy significantly reduced bradykinesia, rigidity, resting tremor, and improved balance.
• Quantifiable motor scores improved significantly: UPDRS by 65%, CAPIT contralateral limb by 38.2%, ipsilateral limb by 24.2%, and walk scores by 45%.
• Medication-induced contralateral dyskinesia resolved, allowing for better tolerance of higher medication doses.

Conclusions:

• Stereotactic ventral pallidotomy is a safe and effective treatment for Parkinson's disease patients refractory to medical management.
• The procedure offers significant motor symptom relief and reduces disabling dyskinesia without increasing morbidity or mortality.
• Ventral pallidotomy provides a valuable therapeutic option for select PD patients with failed medical therapies.